GlassScriptPhysician profile
Alper Cesmebasi
NPI 1447633516
$2,328.01
in general payments reported to CMS, 2019-2025
11 companies · $608 in 2025
The $608 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $218 · 2021: $360 · 2022: $786 · 2024: $159 · 2025: $608.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $400 · Food and Beverage: $193 · Honoraria: $141 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $33.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $399.50 |
| Food and Beverage | $193.47 |
| Honoraria | $141.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $33.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $924.22 | 2019-2025 | Ams 700 |
| Coloplast Corp | $578.34 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $159.00 | 2024 | |
| Urovant Sciences INC | $157.23 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $143.61 | 2021 | |
| Astellas Pharma US INC | $129.92 | 2019-2022 | |
| Acerus Pharmaceuticals Corporation | $76.41 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $72.34 | 2020-2021 | |
| Blue Earth Diagnostics | $43.49 | 2020-2021 | |
| 180 Medical, INC. | $28.45 | 2019 | |
| Becton, Dickinson and Company | $15.00 | 2025 | Bard X-Force Balloon Dilation Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alper Cesmebasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.